Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Drug Deliv Sci Technol. 2019 Apr 18;52:165–176. doi: 10.1016/j.jddst.2019.04.029

Figure 5.

Figure 5.

SEM images of HPMC-AS LG Extrudates with and without P-CO2; A, B, and C: 30 % Extrudate (30% EFA / 70% HPMC-AS LG without P-CO2) D, E, and F: 30 % Extrudate (30% EFA / 70% HPMC-AS LG with P-CO2) G, H, and I: 40 % Extrudate (40% EFA / 60% HPMC-AS LG without P-CO2) J, K, and L: 40 % Extrudate (40% EFA / 60% HPMC-AS LG with P-CO2) M, N, and O: 50 % Extrudate (50% EFA / 50% HPMC-AS LG without P-CO2) P, Q, and R: 50 % Extrudate (50% EFA / 50% HPMC-AS LG with P-CO2)